SIREN : 809771447
AMS 52 is a French company founded 11 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in CHAUMONT (52000), this company of category PME shows in 2015 a revenue of 218 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2015 |
|---|---|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | N/C | N/C | 218 420 € |
| Net income | 140 521 € | 72 232 € | 91 419 € | 125 741 € | 136 005 € | -51 522 € |
| EBITDA | N/C | N/C | N/C | N/C | N/C | -36 747 € |
| Net margin | N/C | N/C | N/C | N/C | N/C | -23.6% |
In 2024, AMS 52 generates positive net income of 141 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
140 521 €
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 82%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
0.0%
81.967%
18.6%
In 2024, the debt ratio of AMS 52 (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2024, the financial autonomy of AMS 52 (82.0%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
The liquidity ratio (= Current assets / Current liabilities) stands at 398.50. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
398.502
In 2024, the liquidity ratio of AMS 52 (398.50) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Based on 124 transactions of similar company sales (all years), the value of AMS 52 is estimated at 115 440 € (range 43 937€ - 421 572€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare AMS 52 with other companies in the same sector:
The revenue of AMS 52 in 2015 is 218 k€.
Yes, AMS 52 generated a net profit of 141 k€ in 2024.
The headquarters of AMS 52 is located in CHAUMONT (52000), in the department Haute-Marne.
The tax return of AMS 52 is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
AMS 52 operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.